Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 3, 2025 | Mercy BioAnalytics | $59.0M Series B | Paul Meister, Paul Meister, Rob Freelen | Avestria Ventures, BrightEdge Ventures, Bruker, iSelect Fund, Labcorp, Mindshift Capital, Perceptive Xontogeny Venture Fund, Portfolia |